CCL2, CCL18 and sIL-4R in renal, meningeal and pulmonary TB; A 2 year study of patients and contacts

Tuberculosis

Volumn 91, Issue 2, 2011, Pages 140-145

  Mendez, Armando ^a   Hernandez Pando, Rogelio ^b   Contreras, Salvador ^a   Aguilar, Diana ^b   Rook, Graham A W ^c  

^a UNIVERSIDAD VERACRUZANA   (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

CCL18; CCL2; Meningeal tuberculosis; Pulmonary tuberculosis; Renal tuberculosis; sIL 4R

Indexed keywords

CCL18 CHEMOKINE; CHEMOKINE; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL PNEUMONIA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENGUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; KIDNEY TUBERCULOSIS; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MEXICO; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; STATISTICAL ANALYSIS; TH2 CELL; TUBERCULOUS MENINGITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHEMOKINE CCL2; CHEMOKINES; CHEMOKINES, CC; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERLEUKIN-4; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; RECEPTORS, INTERLEUKIN-4; TUBERCULOSIS; TUBERCULOSIS, MENINGEAL; TUBERCULOSIS, PULMONARY; TUBERCULOSIS, RENAL; YOUNG ADULT;

EID: 79952487470     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tube.2010.12.008     Document Type: Article

References (48)

1. M.L. Chen, M.J. Pittet, L. Gorelik, R.A. Flavell, R. Weissleder, and H. von Boehmer Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo Proc Natl Acad Sci U S A 102 2005 419 424 (Pubitemid 40116782)
2. J. Harris, S.A. De Haro, S.S. Master, J. Keane, E.A. Roberts, and M. Delgado T helper 2 cytokines inhibit autophagic control of intracellular Mycobacterium tuberculosis Immunity 27 2007 505 517 (Pubitemid 47418681)
3. A. Mantovani, A. Sica, S. Sozzani, P. Allavena, A. Vecchi, and M. Locati The chemokine system in diverse forms of macrophage activation and polarization Trends Immunol 25 2004 677 686 (Pubitemid 39457982)
4. T.A. Wynn Fibrotic disease and the T(H)1/T(H)2 paradigm Nat Rev Immunol 4 2004 583 594
5. Y.J. Jung, R. LaCourse, L. Ryan, and R.J. North Evidence inconsistent with a negative influence of T helper 2 cells on protection afforded by a dominant T helper 1 response against Mycobacterium tuberculosis lung infection in mice Infect Immun 70 2002 6436 6443 (Pubitemid 35192737)
6. R. Hernandez-Pando, D. Aguilar, M.L. Garcia Hernandez, H. Orozco, and G.A.W. Rook Pulmonary tuberculosis in Balb/c mice with non-functional IL-4 genes; changes in the inflammatory effects of TNF-a and in the regulation of fibrosis Eur J Immunol 34 2004 174 183 (Pubitemid 38111533)
7. C.L. Silva, V.L. Bonato, A.A. Coelho-Castelo, A.O. De Souza, S.A. Santos, and K.M. Lima Immunotherapy with plasmid DNA encoding mycobacterial hsp65 in association with chemotherapy is a more rapid and efficient form of treatment for tuberculosis in mice Gene Ther 12 2005 281 287 (Pubitemid 40220630)
8. D.B. Lowrie, R.E. Tascon, V.L. Bonato, V.M. Lima, L.H. Faccioli, and E. Stavropoulos Therapy of tuberculosis in mice by DNA vaccination Nature 400 1999 269 271 (Pubitemid 29334142)
9. E. Roy, J. Brennan, S. Jolles, and D.B. Lowrie Beneficial effect of anti-interleukin-4 antibody when administered in a murine model of tuberculosis infection Tuberculosis (Edinb) 88 2007 197 202
10. G.A. Rook, K. Dheda, and A. Zumla Immune responses to tuberculosis in developing countries: implications for new vaccines Nat Rev Immunol 5 2005 661 667 (Pubitemid 41113197)
11. D. Dlugovitzky, M.L. Bay, L. Rateni, L. Urizar, C.F. Rondelli, and C. Largacha In vitro synthesis of interferon-gamma, interleukin-4, transforming growth factor-beta and interleukin-1 beta by peripheral blood mononuclear cells from tuberculosis patients: relationship with the severity of pulmonary involvement Scand J Immunol 49 1999 210 217 (Pubitemid 29096319)
12. A.O. Sousa, J.I. Salem, F.K. Lee, M.C. Vercosa, P. Cruaud, and B.R. Bloom An epidemic of tuberculosis with a high rate of tuberculin anergy among a population previously unexposed to tuberculosis, the Yanomami Indians of the Brazilian Amazon Proc Natl Acad Sci U S A 94 1997 13227 13232 (Pubitemid 27518504)
13. J.F. Siawaya, N.B. Bapela, K. Ronacher, N. Beyers, P. van Helden, and G. Walzl Differential expression of IL-4 and IL-4{delta}2, but not TGF-{beta}, TGF-{beta}RII, FOXP3, IFN-{gamma}, T-bet or GATA-3 mRNA in fast and slow responders to anti-tuberculosis treatment Clin Vaccine Immunol 15 2008 1165 1170
14. K. Dheda, J.-S. Chang, R.A. Breen, L.U. Kim, J.A. Haddock, and J.F. Huggett In vivo and in vitro studies of a novel cytokine, Interleukin-4delta2, in pulmonary tuberculosis Am J Resp Crit Care Med 172 2005 501 508 (Pubitemid 41117397)
15. A. Demissie, M. Abebe, A. Aseffa, G. Rook, H. Fletcher, A. Zumla The VACSEL Study Group Healthy individuals that control a latent infection with M. tuberculosis express high levels of Th-1 cytokines and the IL-4 antagonist IL-4d2 J Immunol 172 2004 6938 6943 (Pubitemid 38669133)
16. D. Gu, Z. Chen, H. Zhao, W. Du, F. Xue, and J. Ge T(h)1 (CXCL10) and T(h)2 (CCL2) chemokine expression in patients with immune thrombocytopenia Hum Immunol 2010
17. P.O. Flores-Villanueva, J.A. Ruiz-Morales, C.H. Song, L.M. Flores, E.K. Jo, and M. Montano A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis J Exp Med 202 2005 1649 1658 (Pubitemid 41815871)
18. P. de Nadai, A.S. Charbonnier, C. Chenivesse, S. Senechal, C. Fournier, and J. Gilet Involvement of CCL18 in allergic asthma J Immunol 176 2006 6286 6293
19. A. Prasse, and J. Muller-Quernheim Non-invasive biomarkers in pulmonary fibrosis Respirology 14 2009 788 795
20. H. Blum, M. Wolf, K. Enssle, M. Rollinghoff, and A. Gessner Two distinct stimulus-dependent pathways lead to production of soluble murine interleukin-4 receptor J Immunol 157 1996 1846 1853 (Pubitemid 126449655)
21. T. Jung, K. Wagner, C. Neumann, and C.H. Heusser Enhancement of human IL-4 activity by soluble IL-4 receptors in vitro Eur J Immunol 29 1999 864 871 (Pubitemid 29119065)
22. S.E. Jamieson, E.N. Miller, G.F. Black, C.S. Peacock, H.J. Cordell, and J.M. Howson Evidence for a cluster of genes on chromosome 17q11-q21 controlling susceptibility to tuberculosis and leprosy in Brazilians Genes Immun 5 2004 46 57 (Pubitemid 38967629)
23. P.C. Buijtels, W.W. van de Sande, S. Parkinson, P.L. Petit, M.A. van der Sande, and D. van Soolingen Polymorphism in CC-chemokine ligand 2 associated with tuberculosis in Zambia Int J Tuberc Lung Dis 12 2008 1485 1488
24. Z.E. Xu, Y.Y. Xie, J.H. Chen, L.L. Xing, A.H. Zhang, and B.X. Li [Monocyte chemotactic protein-1 gene polymorphism and monocyte chemotactic protein-1 expression in Chongqing Han children with tuberculosis] Zhonghua Er Ke Za Zhi 47 2009 200 203
25. T. Thye, S. Nejentsev, C.D. Intemann, E.N. Browne, M.A. Chinbuah, and J. Gyapong MCP-1 promoter variant -362C associated with protection from pulmonary tuberculosis in Ghana, West Africa Hum Mol Genet 18 2009 381 388
26. G. Ferrara, B. Bleck, L. Richeldi, J. Reibman, L.M. Fabbri, and W.N. Rom Mycobacterium tuberculosis induces CCL18 expression in human macrophages Scand J Immunol 68 2008 668 674
27. A. Pivarcsi, M. Gombert, M.C. Dieu-Nosjean, A. Lauerma, R. Kubitza, and S. Meller CC chemokine ligand 18, an atopic dermatitis-associated and dendritic cell-derived chemokine, is regulated by staphylococcal products and allergen exposure J Immunol 173 2004 5810 5817 (Pubitemid 39392171)
28. M. Kodera, M. Hasegawa, K. Komura, K. Yanaba, K. Takehara, and S. Sato Serum pulmonary and activation-regulated chemokine/CCL18 levels in patients with systemic sclerosis: a sensitive indicator of active pulmonary fibrosis Arthritis Rheum 52 2005 2889 2896 (Pubitemid 41369120)
29. Z. Hasan, J.M. Cliff, H.M. Dockrell, B. Jamil, M. Irfan, and M. Ashraf CCL2 responses to Mycobacterium tuberculosis are associated with disease severity in tuberculosis PLoS One 4 2009 e8459
30. M. Ruhwald, M. Bjerregaard-Andersen, P. Rabna, J. Eugen-Olsen, and P. Ravn IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay BMC Res Notes 2 2009 19
31. Z. Hasan, B. Jamil, J. Khan, R. Ali, M.A. Khan, and N. Nasir Relationship between circulating levels of IFN-gamma, IL-10, CXCL9 and CCL2 in pulmonary and extrapulmonary tuberculosis is dependent on disease severity Scand J Immunol 69 2009 259 267
32. A.L. Alessandri, A.L. Souza, S.C. Oliveira, G.C. Macedo, M.M. Teixeira, and A.L. Teixeira Concentrations of CXCL8, CXCL9 and sTNFR1 in plasma of patients with pulmonary tuberculosis undergoing treatment Inflamm Res 55 2006 528 533 (Pubitemid 46130061)
33. S.L. Deshmane, S. Kremlev, S. Amini, and B.E. Sawaya Monocyte chemoattractant protein-1 (MCP-1): an overview J Interferon Cytokine Res 29 2009 313 326
34. H. Bruhl, J. Cihak, M.A. Schneider, J. Plachy, T. Rupp, and I. Wenzel Dual role of CCR2 during initiation and progression of collagen-induced arthritis: evidence for regulatory activity of CCR2+ T cells J Immunol 172 2004 890 898 (Pubitemid 38113746)
35. L. Gu, S. Tseng, R.M. Horner, C. Tam, M. Loda, and B.J. Rollins Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1 Nature 404 2000 407 411 (Pubitemid 30164344)
36. W.J. Karpus, N.W. Lukacs, K.J. Kennedy, W.S. Smith, S.D. Hurst, and T.A. Barrett Differential CC chemokine-induced enhancement of T helper cell cytokine production J Immunol 158 1997 4129 4136 (Pubitemid 127483911)
37. H. Nakajima, M. Kobayashi, R.B. Pollard, and F. Suzuki Monocyte chemoattractant protein-1 enhances HSV-induced encephalomyelitis by stimulating Th2 responses J Leukoc Biol 70 2001 374 380 (Pubitemid 32826124)
38. W.K. Ip, C.K. Wong, and C.W. Lam Interleukin (IL)-4 and IL-13 up-regulate monocyte chemoattractant protein-1 expression in human bronchial epithelial cells: involvement of p38 mitogen-activated protein kinase, extracellular signal-regulated kinase 1/2 and Janus kinase-2 but not c-Jun NH2-terminal kinase 1/2 signalling pathways Clin Exp Immunol 145 2006 162 172 (Pubitemid 43893946)
39. J.L. Owen, D.M. Lopez, J.F. Grosso, K.M. Guthrie, L.M. Herbert, and M. Torroella-Kouri The expression of CCL2 by T lymphocytes of mammary tumor bearers: role of tumor-derived factors Cell Immunol 235 2005 122 135 (Pubitemid 41597476)
40. A.R. Sousa, S.J. Lane, J.A. Nakhosteen, T. Yoshimura, T.H. Lee, and R.N. Poston Increased expression of the monocyte chemoattractant protein-1 in bronchial tissue from asthmatic subjects Am J Respir Cell Mol Biol 10 1994 142 147
41. M.C. Braun, E. Lahey, and B.L. Kelsall Selective suppression of IL-12 production by chemoattractants J Immunol 164 2000 3009 3017 (Pubitemid 30148960)
42. A. Alcais, C. Fieschi, L. Abel, and J.L. Casanova Tuberculosis in children and adults: two distinct genetic diseases J Exp Med 202 2005 1617 1621 (Pubitemid 41815866)
43. S.F. Chu, C.M. Tam, H.S. Wong, K.M. Kam, Y.L. Lau, and A.K. Chiang Association between RANTES functional polymorphisms and tuberculosis in Hong Kong Chinese Genes Immun 8 2007 475 479 (Pubitemid 47365613)
44. C. Szalai, G.T. Kozma, A. Nagy, A. Bojszko, D. Krikovszky, and T. Szabo Polymorphism in the gene regulatory region of MCP-1 is associated with asthma susceptibility and severity J Allergy Clin Immunol 108 2001 375 381 (Pubitemid 32881058)
45. T. Perkmann, H. Winkler, W. Graninger, P.G. Kremsner, and S. Winkler Circulating levels of the interleukin (IL)-4 receptor and of IL-18 in patients with Plasmodium falciparum malaria Cytokine 29 2005 153 158 (Pubitemid 40126233)
46. D.K. Sang, J.H. Ouma, C.C. John, C.C. Whalen, C.L. King, and A.A. Mahmoud Increased levels of soluble interleukin-4 receptor in the sera of patients with visceral leishmaniasis J Infect Dis 179 1999 743 746 (Pubitemid 30016168)
47. U. Schauer, M. Schmitt, S. Muller, K. Enssle, R. Kurrle, and U. Sundermann Soluble interleukin-4 receptor in atopic children Int Arch Allergy Immunol 108 1995 175 182
48. M. Benson, G. Wennergren, M. Fransson, and L.O. Cardell Altered levels of the soluble IL-1, IL-4 and TNF receptors, as well as the IL-1 receptor antagonist, in intermittent allergic rhinitis Int Arch Allergy Immunol 134 2004 227 232 (Pubitemid 38813036)